1,4-PREGNADIEN-6ALPHA,9ALPHA-DIFLUORO-11BETA,16ALPHA,17,21-TETROL-3,20-DIONE 16,17-ACETONIDE 21-ACETATE

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers, 8 USDMF, 2 JDMF, 1 KDMF, 7 NDC API, 10 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Imports

DOSSIERs // Finished Dosage Forms

62 Dossiers, 47 FDA Orange Book, 8 Europe, 6 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.05%, SOLUTION;TOPICAL - 0.05%, CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1%

RELATED EXCIPIENT COMPANIES

Suppliers, 14 BASF, 8 Nanjing Well Pharmaceutical, 6 Actylis, 6 Kerry, 3 Gangwal Chemicals, 2 Nomisma Healthcare, 2 Finar, 2 Corel Pharma Chem, 2 Seppic, 2 Lubrizol Life Science Health, 2 Microlex e.U, 2 Seqens, 1 Pharm-RX Chemical, 1 Minakem

EXCIPIENTS BY APPLICATIONS

22 Topical, 14 Solubilizers, 10 Parenteral, 7 Thickeners and Stabilizers, 5 Controlled & Modified Release, 5 Co-Processed Excipients, 4 Film Formers & Plasticizers, 4 Surfactant & Foaming Agents, 4 Emulsifying Agents, 3 Coating Systems & Additives, 2 API Stability Enhancers, 2 Granulation, 2 Lubricants & Glidants, 1 Fillers, Diluents & Binders, 1 Direct Compression

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 23 Finished Drug Prices

MARKET PLACE

4 APIs

4 APIs

ANALYTICAL SOLUTION(s)

1 USP Standards, 2 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 15 News

Manufacturers & Suppliers of 1,4-PREGNADIEN-6ALPHA,9ALPHA-DIFLUORO-11BETA,16ALPHA,17,21-TETROL-3,20-DIONE 16,17-ACETONIDE 21-ACETATE Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

1,4-PREGNADIEN-6ALPHA,9ALPHA-DIFLUORO-11BETA,16ALPHA,17,21-TETROL-3,20-DIONE 16,17-ACETONIDE 21-ACETATE

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

18 Suppliers

8 USDMF

2 JDMF

1 KDMF

7 NDC API

10 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Imports

DOSSIERs // Finished Dosage Forms

62 Dossiers

47 FDA Orange Book

8 Europe

6 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITION

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.05%

SOLUTION;TOPICAL - 0.05%

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1%

RELATED EXCIPIENT COMPANIES

Suppliers

14 BASF

8 Nanjing Well Pharmaceutical

6 Actylis

6 Kerry

3 Gangwal Chemicals

2 Nomisma Healthcare

2 Finar

2 Corel Pharma Chem

2 Seppic

2 Lubrizol Life Science Health

2 Microlex e.U

2 Seqens

1 Pharm-RX Chemical

1 Minakem

EXCIPIENTS BY APPLICATIONS

22 Topical

14 Solubilizers

10 Parenteral

7 Thickeners and Stabilizers

5 Controlled & Modified Release

5 Co-Processed Excipients

4 Film Formers & Plasticizers

4 Surfactant & Foaming Agents

4 Emulsifying Agents

3 Coating Systems & Additives

2 API Stability Enhancers

2 Granulation

2 Lubricants & Glidants

1 Fillers, Diluents & Binders

1 Direct Compression

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions

23 Finished Drug Prices

MARKET PLACE

4 APIs

ANALYTICAL SOLUTION(s)

1 USP Standards

2 JP Standards

1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

15 News

1,4-PREGNADIEN-6ALPHA,9ALPHA-DIFLUORO-11BETA,16ALPHA,17,21-TETROL-3,20-DIONE 16,17-ACETONIDE 21-ACETATE

Ascent Innovative Medicines

Fluocinonide

Cream

0.1%

India

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons